Posts by: Iqra Mumal, PhD

News

Testing for additional biomarkers along with the well-known biomarker CA125 can improve the detection of early-stage ovarian cancer, a new study shows. The blood-based assay could significantly improve patient ... Read more

June 24, 2019

Researchers Work to Create Screening Tool for Early or Pre-cancerous OC

News

Researchers from Clemson University and doctors from South Carolina’s Prisma Health-Upstate are collaborating to develop a screening tool that can identify ovarian cancer in its earlier stages, or even ... Read more

June 17, 2019

Sentinel Node Biopsy Feasible to Determine Spread of Early-stage OC

News

A sentinel node biopsy, used to determine whether cancer has spread to lymph nodes, is a feasible way to obtain information and avoid lymph node dissection in patients with ... Read more

May 13, 2019May 13, 2019

ctDNA Sampling May Help Tailor Treatment for Difficult-to-Treat Ovarian Cancer, Study Suggests

News

An analysis of circulating tumor DNA, or ctDNA, can help guide treatment decisions for patients with difficult-to-treat high-grade serous ovarian cancer, a study shows. The study, “Prospective Longitudinal ctDNA ... Read more

May 3, 2019

New Imaging-Guided System Helps Surgeons Remove Tiny Ovarian Tumors

News

A new imaging-guided surgical technique that makes ovarian cancer tumors glow under near-infrared light can help surgeons remove tumors as small as 0.3 millimeters, a study in mice shows. ... Read more

April 22, 2019

Lynparza Plus Investigational Alpelisib Is Promising for Epithelial Ovarian Cancer

News

A combination of Lynparza (olaparib) and the investigational PI3K inhibitor alpelisib is safe for the treatment of recurrent epithelial ovarian cancer and induces at least stable disease in more ... Read more

April 12, 2019April 12, 2019

Long-term Use of Oral Contraceptives Protects Against Deadliest Forms of Ovarian Cancer, Large Study Finds

News

Long-term use of oral contraceptives protects women from the most lethal types of ovarian cancers, a large multi-center study has found. The study, “Oral contraceptive use and risk of ... Read more

September 17, 2018

Two-pronged Antibody Can Help Efficiently Destroy Ovarian Cancer Cells, Researchers Find

News

A newly developed two-pronged antibody is 100 times more effective at destroying ovarian cancer cells than other antibodies in clinical trials, according to researchers at the University of Virginia ... Read more

July 23, 2018

Post-diagnosis Use of Anti-Inflammatory Meds May Improve Ovarian Cancer-specific Survival, Study Suggests

News

Regular use of anti-inflammatory medication, such as aspirin, after an ovarian cancer diagnosis appears to improve ovarian cancer-specific survival, a study shows. The study, “Pre-diagnosis and post-diagnosis use of ... Read more

May 18, 2018

Protein Levels Could Replace Genetic Tests for Detecting ARID1A Mutations

News

A laboratory technique that measures protein levels in tissue samples — called immunohistochemistry (IHC) — is a quicker and less expensive alternative to detect ARID1A mutations in patients with ovarian and ... Read more

Posts by: Iqra Mumal, PhD

Iqra Mumal, PhD

Testing for Multiple Biomarkers at a Time Can Increase Early Detection of OC

Researchers Work to Create Screening Tool for Early or Pre-cancerous OC

Sentinel Node Biopsy Feasible to Determine Spread of Early-stage OC

ctDNA Sampling May Help Tailor Treatment for Difficult-to-Treat Ovarian Cancer, Study Suggests

New Imaging-Guided System Helps Surgeons Remove Tiny Ovarian Tumors

Lynparza Plus Investigational Alpelisib Is Promising for Epithelial Ovarian Cancer

Long-term Use of Oral Contraceptives Protects Against Deadliest Forms of Ovarian Cancer, Large Study Finds

Two-pronged Antibody Can Help Efficiently Destroy Ovarian Cancer Cells, Researchers Find

Post-diagnosis Use of Anti-Inflammatory Meds May Improve Ovarian Cancer-specific Survival, Study Suggests

Protein Levels Could Replace Genetic Tests for Detecting ARID1A Mutations

Pin It on Pinterest